MIRA INFORM REPORT
|
Report Date : |
28.10.2013 |
IDENTIFICATION DETAILS
|
Name : |
NNE PHARMAPLAN INDIA LIMITED (w.e.f. 27.06.2008) |
|
|
|
|
Formerly Known
As : |
PHARMAPLAN ( |
|
|
|
|
Registered
Office : |
A-2/118, Safdarjung Enclave, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
30.12.1997 |
|
|
|
|
Com. Reg. No.: |
55-091387 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.5.000
millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U51507DL1997PLC091387 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELP08616G |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACP6863D |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject’s
primary objective is to provide services as technical and industrial
consultants and engineers, acts as advisors and consultants in the field of
pharmaceutical, Bio-technology and health-care. |
|
|
|
|
No. of Employees
: |
100 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (46) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 318000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject is an
established company having a satisfactory track record. Trade relations are
reported as fair. Business is active. Payments are reported to be usually
correct and as per commitments. The company can
be considered normal for business dealings at usual trade terms and
conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very
High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
The finance ministry
has started preparations for Budget 2014/15. With general elections scheduled
to be held by May next year, there will only be an interim budget. The new
government will present the fiscal Budget.
The Supreme Court
has barred clinical trials for new drugs till a monitoring mechanism is put in
place to protect the lives of people on which the drugs are tested.
Mumbai has been
named the world’s second most honest city according to a survey on 15 cities
worldwide by Readers’ Digest magazine. Finnish capital
3.7 % Growth of the
core sector in August, a seven month high. This takes the overall growth in
April-August this year to 2.3 % compared with 6.3 % in the corresponding period
next financial year.
$19 million
Estimated average spending by companies across the globe including
Rising inflation,
fewer employment avenues and dwindling earnings are taking a toll on the
spending capacity in
Analysts believe the
shutdown of the
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. Mahesh |
|
Designation : |
Accounts Department |
|
Contact No.: |
91-120-4775100 |
|
Date : |
28.10.2013 |
LOCATIONS
|
Registered Office : |
A-2/118, Safdarjung Enclave, |
|
Tel. No.: |
91-11-26197251/ 52 |
|
Fax No.: |
91-11-25197253 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Branch Office 1 : |
B-15, Sector 2, Noida – 201 301, |
|
Tel. No.: |
91-120-4775100 |
|
Fax No.: |
91-120-4775200/ 4775300 |
|
|
|
|
Branch Office 2 : |
#12, Achiah Shetty Layout, RMV Extension, Sadashivnagar, |
|
Tel. No.: |
91-80-49056300 |
|
Fax No.: |
91-80-23617240 |
|
|
|
|
Branch Office 3 : |
703-704, |
|
Tel. No.: |
91-22-40647000 |
|
Fax No.: |
91-22-40647099 |
|
|
|
|
Overseas Office : |
Located at: ·
·
·
·
·
·
·
·
·
·
|
DIRECTORS
AS ON 29.09.2012
|
Name : |
Dr. Anil Kumar Singal |
||||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||||
|
Address : |
E-85, First Floor, Greater Kailash Part-II, |
||||||||||||||||||
|
Date of Birth/Age : |
12.05.1952 |
||||||||||||||||||
|
Qualification : |
M.S. |
||||||||||||||||||
|
Date of Appointment : |
01.04.2013 |
||||||||||||||||||
|
DIN No.: |
00996198 |
||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||
|
|
|
||||||||||||||||||
|
Name : |
Mr. Narendra Prasad |
||||||||||||||||||
|
Designation : |
Whole-Time Director |
||||||||||||||||||
|
Address : |
64, Ground Floor, Block-III, |
||||||||||||||||||
|
Date of Birth/Age : |
06.09.1961 |
||||||||||||||||||
|
Date of Appointment : |
01.04.2013 |
||||||||||||||||||
|
DIN No.: |
00994462 |
||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||
|
|
|||||||||||||||||||
|
Name : |
Mr. George Johann Jakobi |
||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||
|
Address : |
Hardtstr 19, 51250, Usingen (Kransberg), |
||||||||||||||||||
|
Date of Birth/Age : |
11.06.1950 |
||||||||||||||||||
|
Date of Appointment : |
01.01.2000 |
||||||||||||||||||
|
DIN No.: |
00996318 |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Name : |
Hartmut Karl
Schaz
|
||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||
|
Address : |
AM Konigshof 4, 60388, |
||||||||||||||||||
|
Date of Birth/Age : |
11.01.1967 |
||||||||||||||||||
|
Date of Appointment : |
01.07.2002 |
||||||||||||||||||
|
DIN No.: |
00996129 |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Name : |
Ole Cato Spanghanssen |
||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||
|
Address : |
Kejserensvej 3, 1, 3480 Fredensborg 3480 |
||||||||||||||||||
|
Date of Birth/Age : |
10.05.1958 |
||||||||||||||||||
|
Date of Appointment : |
30.09.2011 |
||||||||||||||||||
|
DIN No.: |
03437655 |
||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Mahesh |
|
Designation : |
Accounts Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
Anil Kumar Singal |
|
20 |
|
Sunita Singal |
|
10 |
|
Rajendra Kumar Taneja |
|
10 |
|
Rajiv Mohan Goswami |
|
10 |
|
Madhu Sahni |
|
10 |
|
NNE Pharmaplan |
|
49930 |
|
Anubhav Singal |
|
10 |
|
Total
|
|
50000 |
AS ON 29.09.2012
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others] |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject’s
primary objective is to provide services as technical and industrial
consultants and engineers, acts as advisors and consultants in the field of
pharmaceutical, Bio-technology and health-care. |
|
|
|
|
Terms : |
|
|
Selling : |
Credit |
|
|
|
|
Purchasing : |
Credit |
GENERAL INFORMATION
|
Customers : |
End Users |
|
|
|
|
No. of Employees : |
100 (Approximately) |
|
|
|
|
Bankers : |
Standard Chartered Bank, Noida, |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Price Waterhouse Chartered Accountants |
|
Address : |
7th and 8th Floor, Tower-B, |
|
PAN No.: |
AAEFP3641G |
|
|
|
|
Holding
Company: |
NNE Pharmaplan |
|
|
|
|
Ultimate
Holding Company: |
NNE
Pharmaplan A/S, |
|
|
|
|
Fellow
Subsidiaries: |
|
CAPITAL STRUCTURE
AS ON 29.09.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
200000 |
Equity Shares |
Rs.100/- each |
Rs.20.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50000 |
Equity Shares |
Rs.100/-
each |
Rs.5.000
millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are in
Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2012 |
31.03.2011 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1) Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
5.000 |
5.000 |
|
(b) Reserves & Surplus |
|
74.556 |
46.592 |
|
(c) Money received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
79.556 |
51.592 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
|
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
|
0.000 |
0.000 |
|
(c)
Other long term liabilities |
|
0.000 |
0.000 |
|
(d)
Long-term provisions |
|
2.083 |
6.030 |
|
Total
Non-current Liabilities (3) |
|
2.083 |
6.030 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
|
10.249 |
9.939 |
|
(b)
Trade payables |
|
36.553 |
14.368 |
|
(c)
Other current liabilities |
|
44.698 |
48.107 |
|
(d)
Short-term provisions |
|
4.577 |
0.792 |
|
Total
Current Liabilities (4) |
|
96.077 |
73.206 |
|
|
|
|
|
|
TOTAL |
|
177.716 |
130.828 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i)
Tangible assets |
|
21.861 |
18.897 |
|
(ii)
Intangible Assets |
|
1.257 |
1.628 |
|
(iii)
Capital work-in-progress |
|
0.816 |
0.076 |
|
(iv) Intangible assets under development |
|
0.000 |
0.000 |
|
(b) Non-current
Investments |
|
0.000 |
0.000 |
|
(c) Deferred tax assets
(net) |
|
8.648 |
8.282 |
|
(d) Long-term Loan
and Advances |
|
10.719 |
12.799 |
|
(e)
Other Non-current assets |
|
0.794 |
0.763 |
|
Total
Non-Current Assets |
|
44.095 |
42.445 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
|
0.000 |
0.000 |
|
(b)
Inventories |
|
0.000 |
0.000 |
|
(c)
Trade receivables |
|
48.443 |
37.447 |
|
(d)
Cash and cash equivalents |
|
1.330 |
6.353 |
|
(e)
Short-term loans and advances |
|
34.481 |
26.602 |
|
(f)
Other current assets |
|
49.367 |
17.981 |
|
Total
Current Assets |
|
133.621 |
88.383 |
|
|
|
|
|
|
TOTAL |
|
177.716 |
130.828 |
|
SOURCES OF FUNDS |
|
|
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
|
5.000 |
|
|
2] Share Application Money |
|
|
0.000 |
|
|
3] Reserves & Surplus |
|
|
84.984 |
|
|
4] (Accumulated Losses) |
|
|
0.000 |
|
|
NETWORTH |
|
|
89.984 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
0.000 |
|
|
2] Unsecured Loans |
|
|
0.000 |
|
|
TOTAL BORROWING |
|
|
0.000 |
|
|
DEFERRED TAX LIABILITIES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
89.984 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
24.085 |
|
|
Capital work-in-progress |
|
|
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
0.000 |
|
|
DEFERRED TAX ASSETS |
|
|
3.182 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
0.000 |
|
|
Sundry Debtors |
|
|
69.917 |
|
|
Cash & Bank Balances |
|
|
18.836 |
|
|
Other Current Assets |
|
|
0.793 |
|
|
Loans & Advances |
|
|
28.423 |
|
Total
Current Assets |
|
|
117.969 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
35.467 |
|
|
Other Current Liabilities |
|
|
14.585 |
|
|
Provisions |
|
|
5.200 |
|
Total
Current Liabilities |
|
|
55.252 |
|
|
Net Current Assets |
|
|
62.717 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
89.984 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue
from Operations |
250.317 |
124.757 |
183.496 |
|
|
|
Other Income |
0.702 |
2.932 |
2.387 |
|
|
|
TOTAL (A) |
251.019 |
127.689 |
185.883 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Employee Benefits Expenses |
89.686 |
71.302 |
|
|
|
|
Other Expenses |
124.907 |
93.521 |
|
|
|
|
TOTAL (B) |
214.593 |
164.823 |
156.173 (Including
Financial Expenses) |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
36.426 |
(37.134) |
|
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
1.205 |
0.413 |
|
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
35.221 |
(37.547) |
29.710 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
5.861 |
5.912 |
7.181 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
29.360 |
(43.459) |
22.529 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
1.396 |
(5.067) |
7.787 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
27.964 |
(38.392) |
14.742 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’ BALANCE
BROUGHT FORWARD |
46.592 |
84.984 |
NA |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
74.556 |
46.592 |
NA |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Business Income
and Reimbursement of Expenses |
13.020 |
19.699 |
19.052 |
|
|
TOTAL EARNINGS |
13.020 |
19.699 |
19.052 |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
559.28 |
(767.84) |
NA |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
11.14
|
(30.07) |
7.93 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
11.73
|
(34.83) |
12.28 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
17.45
|
(35.49) |
15.86 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.37
|
(0.84) |
0.25 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.13
|
0.19 |
0.00 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.39
|
1.21 |
2.14 |
LOCAL AGENCY FURTHER INFORMATION
|
Check
List by Info Agents |
Available
in Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
Yes |
|
20) Export / Import details (if
applicable) |
No |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
Yes |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
Yes |
|
30) Major Shareholders, if available |
Yes |
|
31)
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32)
PAN of Proprietor/Partner/Director, if available |
No |
|
33)
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34)
External Agency Rating, if available |
No |
LITIGATION
DETAILS:
IN THE HIGH COURT
OF DELHI AT NEW DELHI
CS(OS) 2532/2012
NIRMAN
CONSULTANTS PRIVATE LIMITED ..... Plaintiff
Through: Ms.
Anisha Jain, Advocate with Mr. Atul Agarwal, Advocate.
versus
NNE PHARMAPLAN
INDIA LIMITED ..... Defendant
Through: Mr.
Sagar Chandra, Advocate with Mr. Ankit Rastogi, Advocate.
CORAM:
HON'BLE MR. JUSTICE VALMIKI J. MEHTA
ORDER
22.08.2012
I.A.
No.15087/2012 (under Section 149 CPC)
Counsel for the plaintiff states that Court fees amount has already been
deposited. Let the Court fees be filed within a period of one week of
receiving of the same from the concerned authority.
I.A. stands
disposed of.
CS(OS) No.2532/2012 and I.A. No.15086/2012 (under Order 39 Rules 1 and 2 CPC)
1. Summons in the suit and notices in the application be issued to
the defendant.
2. Counsel appears for the defendant and accepts the summon in the suit and
notice in the application. Written statement and reply be filed within a period
of four weeks from today. Replication, if any, be filed within four weeks
thereafter. Parties will file documents in their power and possession alongwith
the pleadings. Admission/denial of the documents of the opposite side will be
done by preparing an index of the documents of the other party and adding an
additional column which will contain the endorsement of admission/denial.
Affidavits be filed in support of admission/denial of the documents.
3. List before the Joint Registrar for marking of the exhibits to the
documents on 30th October, 2012.
VALMIKI J. MEHTA, J
AUGUST 22, 2012
Note:
No Charges Exist for Company
|
Unsecured Loan |
31.03.2012 (Rs.
in Millions) |
31.03.2011 (Rs.
in Millions) |
|
SHORT
TERM BORROWINGS |
|
|
|
Working
capital loan repayable on demand from Citibank (Working
capital loan from bank is secured by corporate bank guarantee given by the
ultimate Holding Company NNE Pharmaplan A/S, |
10.249 |
9.939 |
|
Total
|
10.249 |
9.939 |
COMPANY OVERVIEW:
The Company
was incorporated on 30th December, 1997 under the provisions of the
Companies Act, 1956 as a limited company. The Company's primary objective is to
provide services as technical and industrial consultants and engineers, acts as
advisors and consultants in the field of pharmaceutical, Bio-technology and
health-care.
The Company
is a Small and Medium Sized Company (SMC) as defined in The Companies (Accounting
Standards) Rules, 2006 in respect of Accounting Standards notified under the
Companies Act, 1956. Accordingly, the Company has complied with the Accounting
Standards as applicable to a Small and Medium Sized Company.
OPERATIONS:
The Company's performance
regained in the year and its operations are back on track; the total revenue
nearly doubled from preceding year The Company recorded revenue during the year
of Rs.251.019 millions as compared to Rs.127.689 millions in the preceding
year. Also the Company recorded a net profit of Rs.27.964 millions as against
loss of Rs.38.392 millions in the previous fiscal Innovative measures aimed at
attaining improved processes and higher efficiencies enabled the Company to
strengthen its position in competitive market Further, the year witnessed
upward trend in the Order inflow for the Company. The Company as a result of various initiatives taken by it
was well positioned to accept and service the higher Order-intake during the
year. The basic strength of the Company is to maintain
excellence in quality and technology and the quality standards are never
compromised. Continuous improved performances have enabled the Company to
strengthen its position in competitive market.
FIXED ASSETS:
Tangible Assets (Own Assets)
·
Air Conditioner
·
Furniture and Fixtures
·
Vehicle
·
Office Equipment
·
Computers
·
Books and Guide
Intangible Assets (Own Assets - Acquired)
·
Computer Software
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.63 |
|
|
1 |
Rs.99.94 |
|
Euro |
1 |
Rs.85.14 |
INFORMATION DETAILS
|
Information
Gathered by : |
PLK |
|
|
|
|
Report Prepared
by : |
SMN |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTERS |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
46 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.